Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemours CoCC · Entity 4420 | Director | August 07, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemours Co
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,988.0387 |
Reported balance
After 2026-08-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-07 · Purchase · Acquired 13,000 · Balance 56,988.0387 F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $15.58 to $15.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2: Includes directly owned shares, restricted stock units and dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $15.58 to $15.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: Includes directly owned shares, restricted stock units and dividend equivalent units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2026 Filed Aug 11, 2026 20:10 UTC | Chemours Co CC · Entity 4420 | PurchaseCommon Stock | 13,000 | $15.62 | $203,060.00 |
DisclosureSEC source: 0001193125-26-344635 · ownership.xml · nonDerivative · entry 1 Cowan Alister · CIK 0002002664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,988.0387 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $15.58 to $15.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:15 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 7,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-214664 · ownership.xml · nonDerivative · entry 1 Cowan Alister · CIK 0002002664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,881.0397 F1 · shares: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board. F2 · balance_after: Includes deferred stock units and dividend equivalent units. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 21:36 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 14,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-007927 · form4.xml · nonDerivative · entry 1 Cowan Alister · CIK 0002002664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,830.7011 F1 · shares: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the board. F2 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:11 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 10,200 | $19.26 | $196,471.38 |
DisclosureSEC source: 0001062993-24-019347 · form4.xml · nonDerivative · entry 1 Cowan Alister · CIK 0002002664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,582.761 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $19.16 to $19.30. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:53 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 8,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-014614 · form4.xml · nonDerivative · entry 1 Cowan Alister · CIK 0002002664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,226.4044 F1 · shares: Represents stock units that will convert one-for-one to Chemours common stock upon the third anniversary of the grant date. F2 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:26 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 2,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022859 · form4.xml · nonDerivative · entry 1 Cowan Alister · CIK 0002002664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,628 F1 · balance_after: Includes stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.